| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |